[Platelet aggregation and various coagulation parameters in liver cirrhosis]

Area of Science:

• Hematology
• Hepatology
• Clinical Biochemistry

Context:

• Liver cirrhosis is a significant global health issue.
• Coagulation disorders are common in patients with liver cirrhosis.
• Platelet dysfunction contributes to the complications of liver disease.

Purpose:

• To investigate platelet function and coagulation parameters in liver cirrhosis.
• To compare these parameters between cirrhotic patients and healthy controls.
• To identify potential intrinsic platelet defects in liver cirrhosis.

Summary:

• Platelet aggregation induced by adenosine diphosphate (ADP) and epinephrine was significantly lower in 28 cirrhotic patients compared to 44 age-matched controls.
• Platelet factor 3 (PF3) availability, a marker of platelet activation, was also reduced in cirrhotic patients.
• Coagulation tests revealed prolonged activated partial thromboplastin time (aPTT) and prothrombin ratio, alongside decreased levels of antithrombin III, fibrinogen, and platelet count in the cirrhotic group.

Impact:

• Findings suggest intrinsic platelet defects contribute to hemostatic abnormalities in liver cirrhosis.
• Highlights the need for careful monitoring of coagulation status in cirrhotic patients.
• Provides insights into the pathophysiology of bleeding complications in liver disease.